To the Editor: Imatinib mesylate (Gleevec [Glivec], Novartis), a protein kinase inhibitor of c-kit receptor tyrosine kinase (KIT) and platelet-derived growth factor receptor α (PGFR-α), is widely u...
No takes yet. Share an insight, caveat, or question.
Penel et al. (2008) studied this question.